The Effect of Primary Percutaneous Coronary Intervention after the Administration of Tirofiban Alone or Tirofiban Combined with Low dose Alteplase in Patients with Acute Myocardial Infarction on ST Elevation Resolution, TIMI Flow and Short-Term Clinical O.
10.4070/kcj.2005.35.5.362
- Author:
Sang Pil KIM
;
Jang Hyun CHO
;
Dong Ryeol CHAE
;
Sang Min YEOM
;
Won Jung JEON
;
Su Hyun KIM
;
Young Sang O
;
Hyuk Seung YANG
;
Dong Han KIM
;
Yeol BAE
;
Joon Young KIM
;
Myung Ho JEONG
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
Myocardial infarction;
Angioplasty;
Thrombolysis, therapeutic;
Electrocardiography
- MeSH:
Angioplasty;
Aspirin;
Blood Platelets;
Electrocardiography;
Follow-Up Studies;
Glycoproteins;
Hemorrhage;
Heparin;
Humans;
Myocardial Infarction*;
Percutaneous Coronary Intervention*;
Thrombolytic Therapy;
Tissue Plasminogen Activator*
- From:Korean Circulation Journal
2005;35(5):362-368
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: The combination of platelet glycoprotein IIb/IIIa inhibitors and a low dose thrombolytic agent may produce early Thrombolysis In Myocardial Infarction (TIMI) 3 flow and a high rate of ST elevation resolution in an ST elevation acute myocardial infarction (STEMI). The clinical effect of tirofiban combined with low dose alteplase, prior to primary percutaneous coronary intervention (PCI) in STEMI, were evaluated on the ST elevation resolution, TIMI flow and 30-day clinical outcomes. SUBJECTS AND METHODS: Following aspirin, clopidogrel and standard heparin, 45 patients with STEMI were randomized into 2 groups; tirofiban administration (Group I; n=23, 64+/-10 years; 15 male) or combined administration of tirofiban with 40 mg alteplase prior to primary PCI (Group II; n=22, 59+/-11 years; 19 male). The pre- and post-interventional TIMI flow grades, ST elevation resolution and bleeding complications were compared between the two groups. The major adverse cardiac events (MACE) were compared between the two groups during 30-days of clinical follow-up. RESULTS: Group II had a higher pre-interventional TIMI flow (TIMI flow> or =2: 34.8% vs. 90.9%, p<0.0001) and rate of ST elevation resolution (49.0+/-27.8% vs. 66.6+/-27.2%, p=0.045) than Group I. A major bleeding complication developed in 1 (5.0%) Group II patient, and minor bleeding complications developed 1 patient from each group (Group I; 9.5% vs. Group II; 10%, p=0.959). CONCLUSION: Combined administration of tirofiban with alteplase prior to primary PCI leads to a higher TIMI flow and more frequent ST elevation resolution, without bleeding complications, compared to a single administration of tirofiban.
